vs
HYDROFARM HOLDINGS GROUP, INC.（HYFM）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是HYDROFARM HOLDINGS GROUP, INC.的1.4倍（$35.5M vs $25.1M），RECURSION PHARMACEUTICALS, INC.净利率更高（-304.2% vs -963.9%，领先659.6%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -32.7%），HYDROFARM HOLDINGS GROUP, INC.自由现金流更多（$-4.3M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -31.9%）
Hydrofarm Inc.（代码HYFM）是一家美国企业，专业从事可控环境农业设备及用品的研发生产与分销，业务覆盖各类室内种植、可控农业场景所需工具与配套物资，在北美可控农业领域拥有成熟的供应网络。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
HYFM vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $25.1M | $35.5M |
| 净利润 | $-242.2M | $-108.1M |
| 毛利率 | 8.5% | 59.8% |
| 营业利润率 | -953.8% | -304.8% |
| 净利率 | -963.9% | -304.2% |
| 营收同比 | -32.7% | 681.7% |
| 净利润同比 | -1282.7% | 39.6% |
| 每股收益（稀释后） | $-52.09 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $25.1M | $35.5M | ||
| Q3 25 | $29.4M | $5.2M | ||
| Q2 25 | $39.2M | $19.2M | ||
| Q1 25 | $40.5M | $14.7M | ||
| Q4 24 | $37.3M | $4.5M | ||
| Q3 24 | $44.0M | $26.1M | ||
| Q2 24 | $54.8M | $14.4M | ||
| Q1 24 | $54.2M | $13.8M |
| Q4 25 | $-242.2M | $-108.1M | ||
| Q3 25 | $-16.4M | $-162.3M | ||
| Q2 25 | $-16.9M | $-171.9M | ||
| Q1 25 | $-14.4M | $-202.5M | ||
| Q4 24 | $-17.5M | $-178.9M | ||
| Q3 24 | $-13.1M | $-95.8M | ||
| Q2 24 | $-23.4M | $-97.5M | ||
| Q1 24 | $-12.6M | $-91.4M |
| Q4 25 | 8.5% | 59.8% | ||
| Q3 25 | 11.6% | -183.8% | ||
| Q2 25 | 7.1% | -4.9% | ||
| Q1 25 | 17.0% | -48.0% | ||
| Q4 24 | 4.9% | -181.4% | ||
| Q3 24 | 19.4% | 53.7% | ||
| Q2 24 | 19.8% | 36.2% | ||
| Q1 24 | 20.2% | 19.1% |
| Q4 25 | -953.8% | -304.8% | ||
| Q3 25 | -44.1% | -3327.6% | ||
| Q2 25 | -34.0% | -916.8% | ||
| Q1 25 | -27.1% | -1297.9% | ||
| Q4 24 | -40.5% | -4042.4% | ||
| Q3 24 | -20.5% | -377.1% | ||
| Q2 24 | -35.3% | -697.4% | ||
| Q1 24 | -16.1% | -698.4% |
| Q4 25 | -963.9% | -304.2% | ||
| Q3 25 | -55.8% | -3135.3% | ||
| Q2 25 | -43.0% | -894.2% | ||
| Q1 25 | -35.5% | -1373.3% | ||
| Q4 24 | -46.9% | -3935.5% | ||
| Q3 24 | -29.9% | -367.5% | ||
| Q2 24 | -42.8% | -676.6% | ||
| Q1 24 | -23.3% | -662.4% |
| Q4 25 | $-52.09 | $-0.17 | ||
| Q3 25 | $-3.51 | $-0.36 | ||
| Q2 25 | $-3.63 | $-0.41 | ||
| Q1 25 | $-3.12 | $-0.50 | ||
| Q4 24 | $-3.80 | $-0.56 | ||
| Q3 24 | $-2.86 | $-0.34 | ||
| Q2 24 | $-5.10 | $-0.40 | ||
| Q1 24 | $-2.75 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.3M | $743.3M |
| 总债务越低越好 | $50.0K | $9.6M |
| 股东权益账面价值 | $-63.3M | $1.1B |
| 总资产 | $123.8M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $6.3M | $743.3M | ||
| Q3 25 | $10.7M | $659.8M | ||
| Q2 25 | $11.0M | $525.1M | ||
| Q1 25 | $13.7M | $500.5M | ||
| Q4 24 | $26.1M | $594.4M | ||
| Q3 24 | $24.4M | $427.6M | ||
| Q2 24 | $30.3M | $474.3M | ||
| Q1 24 | $24.2M | $296.3M |
| Q4 25 | $50.0K | $9.6M | ||
| Q3 25 | $111.7M | $11.9M | ||
| Q2 25 | $111.6M | $14.2M | ||
| Q1 25 | $110.0M | $16.4M | ||
| Q4 24 | $114.7M | $19.0M | ||
| Q3 24 | $114.8M | $20.5M | ||
| Q2 24 | $114.9M | $22.9M | ||
| Q1 24 | $115.4M | — |
| Q4 25 | $-63.3M | $1.1B | ||
| Q3 25 | $178.3M | $1.0B | ||
| Q2 25 | $195.0M | $919.1M | ||
| Q1 25 | $209.9M | $933.9M | ||
| Q4 24 | $223.7M | $1.0B | ||
| Q3 24 | $243.0M | $524.6M | ||
| Q2 24 | $255.0M | $584.4M | ||
| Q1 24 | $278.0M | $401.2M |
| Q4 25 | $123.8M | $1.5B | ||
| Q3 25 | $369.7M | $1.4B | ||
| Q2 25 | $389.9M | $1.3B | ||
| Q1 25 | $410.6M | $1.3B | ||
| Q4 24 | $426.1M | $1.4B | ||
| Q3 24 | $445.9M | $726.5M | ||
| Q2 24 | $463.4M | $775.9M | ||
| Q1 24 | $494.0M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | 0.63× | 0.01× | ||
| Q2 25 | 0.57× | 0.02× | ||
| Q1 25 | 0.52× | 0.02× | ||
| Q4 24 | 0.51× | 0.02× | ||
| Q3 24 | 0.47× | 0.04× | ||
| Q2 24 | 0.45× | 0.04× | ||
| Q1 24 | 0.42× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.0M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-4.3M | $-47.3M |
| 自由现金流率自由现金流/营收 | -17.1% | -133.1% |
| 资本支出强度资本支出/营收 | 1.3% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-15.1M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $-4.0M | $-46.1M | ||
| Q3 25 | $-37.0K | $-117.4M | ||
| Q2 25 | $1.7M | $-76.4M | ||
| Q1 25 | $-11.8M | $-132.0M | ||
| Q4 24 | $2.7M | $-115.4M | ||
| Q3 24 | $-4.5M | $-59.2M | ||
| Q2 24 | $3.8M | $-82.2M | ||
| Q1 24 | $-2.3M | $-102.3M |
| Q4 25 | $-4.3M | $-47.3M | ||
| Q3 25 | $-207.0K | $-117.6M | ||
| Q2 25 | $1.4M | $-79.6M | ||
| Q1 25 | $-12.0M | $-133.8M | ||
| Q4 24 | $2.4M | $-116.7M | ||
| Q3 24 | $-5.3M | $-63.8M | ||
| Q2 24 | $3.4M | $-83.4M | ||
| Q1 24 | $-3.7M | $-109.0M |
| Q4 25 | -17.1% | -133.1% | ||
| Q3 25 | -0.7% | -2272.5% | ||
| Q2 25 | 3.7% | -413.9% | ||
| Q1 25 | -29.6% | -907.4% | ||
| Q4 24 | 6.4% | -2567.7% | ||
| Q3 24 | -12.0% | -244.6% | ||
| Q2 24 | 6.2% | -578.5% | ||
| Q1 24 | -6.9% | -789.9% |
| Q4 25 | 1.3% | 3.5% | ||
| Q3 25 | 0.6% | 4.7% | ||
| Q2 25 | 0.7% | 16.4% | ||
| Q1 25 | 0.6% | 12.4% | ||
| Q4 24 | 0.7% | 28.6% | ||
| Q3 24 | 1.8% | 17.5% | ||
| Q2 24 | 0.7% | 8.2% | ||
| Q1 24 | 2.7% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
